SOURCE:techcrunch.com
The startup bug has hit the world of biotechnology, and the latest victim is a business that is building a “super glue,” coincidentally, for bug-combating vaccines. SpyBiotech — a startup spun out of Oxford University that has developed a way to bond antigens. view full post
Friday, 31 March 2017
SpyBiotech, which makes a ‘superglue’ for vaccines, raises £4M from GV and Oxford
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment